Lifting the Stigma of HPV-Associated Oropharyngeal Cancer: Insights from Dr. Tom Thomas at Morristown Medical Center - Top-Institutions - MDSpire

Lifting the Stigma of HPV-Associated Oropharyngeal Cancer: Insights from Dr. Tom Thomas at Morristown Medical Center

Although a stigma has persisted surrounding human papillomavirus (HPV)–associated head and neck cancers, a lot of progress has been made through education efforts within the head and neck surgical oncology community.

  • By

  • April 3, 2024

  • 9 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Head and Neck Oncology
    • HPV-related Cancer Research
    • Surgical Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Head and Neck Surgery
    • HPV-related Cancer Epidemiology
    • Radiation Oncology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Otolaryngology
    • Head and Neck Oncology
    • HPV-related Cancer Research

  • #4

    Memorial Sloan Kettering Cancer Center - Leonard B. Kahn Head and Neck Cancer Institute at Morristown Medical Center
    Memorial Sloan Kettering Cancer Center - Leonard B. Kahn Head and Neck Cancer Institute at Morristown Medical Center

    Morristown, NJ

    Key Differentiators

    • Head and Neck Reconstructive Surgery
    • Transoral Robotic Surgery
    • HPV-associated Cancer Counseling

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Head and Neck Oncology
    • HPV-related Cancer Prevention
    • Robotic Surgery

Original Source(s)

Lifting the Stigma of HPV-Associated Oropharyngeal Cancer: Insights from Dr. Tom Thomas at Morristown Medical Center

  • by

  • April 3, 2024

Related Content

Synthetic short RNA in cancer

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort